drugset / Trial / NCT00226447

Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients

NCT00226447

RandomizedParallel-groupOpen-labelTreatment

Summary

The aim is to investigate the best treatment regime of PEG-Intron A and lamivudine combination in terms of viral clearance in chronic hepatitis B patients.

Timeline

Start
2002-12
Primary completion
2006-07
Completion
2006-07

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lamivudine Other / unclassified
Subject PEG-Intron A Unknown